Arix Bioscience is focused on investing in biotech companies, but the VC has a wide footprint. Looking at Arix’s historic investments, there is a greater concentration in the US than one would expect from a venture capital firm headquartered in London, UK. Although Arix is a newer player in the biotech investment arena, its portfolio includes companies that are transitioning through the development life cycle.
“We have had four companies in the public portfolio, – companies that have gone through the IPO process – and the remaining are private companies,” Naseem Amin, executive chair of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
